Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

A qualitative study of underutilization of the AIDS drug assistance program.

Olson KM, Godwin NC, Wilkins SA, Mugavero MJ, Moneyham LD, Slater LZ, Raper JL.

J Assoc Nurses AIDS Care. 2014 Sep-Oct;25(5):392-404. doi: 10.1016/j.jana.2013.11.003. Epub 2014 Feb 4.

2.

Underutilization of the AIDS Drug Assistance Program: associated factors and policy implications.

Godwin NC, Willig JH, Nevin CR, Lin HY, Allison J, Gaddis K, Peterson J, Saag MS, Mugavero MJ, Raper JL.

Health Serv Res. 2011 Jun;46(3):982-95. doi: 10.1111/j.1475-6773.2010.01223.x. Epub 2011 Jan 6.

3.

Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.

Kahn JG, Zhang X, Cross LT, Palacio H, Birkhead GS, Morin SF.

Public Health Rep. 2002 May-Jun;117(3):252-62; discussion 231-2.

4.

Location strongest factor in getting ADAP help.

[No authors listed]

AIDS Alert. 2001 May;16(5):57-8, 53.

PMID:
11590779
5.

Financial Barriers and Lapses in Treatment and Care of HIV-Infected Adults in a Southern State in the United States.

Wohl DA, Kuwahara RK, Javadi K, Kirby C, Rosen DL, Napravnik S, Farel C.

AIDS Patient Care STDS. 2017 Nov;31(11):463-469. doi: 10.1089/apc.2017.0125. Epub 2017 Oct 17.

PMID:
29039984
6.

Is the US AIDS drug assistance program cost-effective?

Pinkerton SD, Kibicho J, Galletly CL.

AIDS Behav. 2013 Jan;17(1):1-4. doi: 10.1007/s10461-012-0321-z.

7.

Defining the need to reform the US AIDS Drug Assistance Program.

Whigham MR.

J Int Assoc Physicians AIDS Care. 1998 Jan;4(1):39-40.

PMID:
11365032
8.

State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards.

Johri M, David Paltiel A, Goldie SJ, Freedberg KA.

Med Care. 2002 May;40(5):429-41.

PMID:
11961477
9.

More patients seek drugs through ADAPs, creating $50 million deficit.

[No authors listed]

AIDS Alert. 2001 May;16(5):53-6.

PMID:
11590777
10.

Impact of zidovudine-based triple combination therapy on an AIDS drug assistance program.

Mauskopf JA, Tolson JM, Simpson KN, Pham SV, Albright J.

J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):302-13.

PMID:
10836752
11.

State variation in AIDS drug assistance program prescription drug coverage for modifiable cardiovascular risk factors.

Blackstock OJ, Wang KH, Fiellin DA.

J Gen Intern Med. 2011 Dec;26(12):1426-33. doi: 10.1007/s11606-011-1807-5. Epub 2011 Aug 12.

12.

The impact of state policy on the costs of HIV infection.

Goldman DP, Bhattacharya J, Leibowitz AA, Joyce GF, Shapiro MF, Bozzette SA.

Med Care Res Rev. 2001 Mar;58(1):31-53; discussion 54-9. Erratum in: Med Care Res Rev 2001 Dec;58(4):497-8.

PMID:
11236232
13.

Southern states receive insufficient ADAP money. North Carolina, Alabama face crises.

[No authors listed]

AIDS Alert. 2004 Aug;19(8):89-90.

PMID:
15300945
14.

ADAP activists needed in all U.S. states and territories.

James JS.

AIDS Treat News. 2004 Aug 27;(404):2-3.

PMID:
15484362
16.

ADAP emergency!

Save ADAP Committee, AIDS Treatment Activists Coalition (ATAC).

GMHC Treat Issues. 2002 Sep;16(9):1-3. No abstract available.

PMID:
12400470
17.

Eligibility policies for the state AIDS drug assistance programs.

Buchanan RJ, Chakravorty BJ, Smith SR.

Soc Work Health Care. 2001;32(3):81-104.

PMID:
11358274
18.

The promise of ADAP.

Montgomery M.

Focus. 2007 Jan;22(1):4-6. No abstract available.

PMID:
17526106
19.

The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women.

Yi T, Cocohoba J, Cohen M, Anastos K, DeHovitz JA, Kono N, Hanna DB, Hessol NA.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):253-62. doi: 10.1097/QAI.0b013e31820a9d04.

20.

ADAP. Report: Alabama has longest wait list for AIDS drugs.

[No authors listed]

AIDS Policy Law. 2004 Dec 31;20(1):9. No abstract available.

PMID:
15651115

Supplemental Content

Support Center